Titelia

Holdings of JOHNSON & JOHNSON

14 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 99.5 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 68.3 %
  • FR 29.2 %
  • KY 2.5 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US12406.3M $68.33 %
2FR1173.6M $29.19 %
3KY114.7M $2.48 %

Positions

RankCompanySharesValueWeight
1Protagonist Therapeutics Inc 2,449,183258.1M $
2NANOBIOTIX SA 5,623,816173.6M $
3Rapport Therapeutics Inc 1,784,51755.8M $
4CVRx Inc 4,024,86138.1M $
5Contineum Therapeutics Inc 1,979,17325.8M $
6LEGEND BIOTECH CORP 814,58614.7M $
7Xencor Inc 748,0629M $
8PROCEPT BIOROBOTICS CORP 357,9399M $
9Fate Therapeutics Inc 3,379,0644.1M $
10Neumora Therapeutics Inc 1,849,4453.6M $
11RALLYBIO CORP 152,9011.4M $
12Vor BioPharma Inc 53,732958.6K $
13Standard BioTools Inc 311,967286.8K $
14Adicet Bio Inc 22,779155.1K $